NIMHD SBIR/STTR Program

NIMHD Parent SBIR Grant

Funds United States small businesses developing health-disparities technologies through NIH SBIR grants.

The NIMHD Parent SBIR Grant is the National Institute on Minority Health and Health Disparities route into the NIH, CDC and FDA parent SBIR R43/R44 notice. The current opportunity number is PA-27-100, posted May 28, 2026, and the Simpler.Grants.gov record lists it as a grant opportunity closing April 5, 2027.

NIMHD's official small-business page says only small businesses located and operating in the United States may apply for SBIR/STTR funding, with no more than 500 employees including affiliates. It also gives NIMHD budget guidance of $306,872 for Phase I and $2,045,816 for Phase II, so this catalog row uses the Phase II figure as the maximum and leaves minimum, pool, and expected award count blank.

This is a company applicant path, not a university grant. The source describes SBIR as helping United States small business concerns bring scientific innovations to the marketplace and supporting feasibility studies through later R&D needed to develop a commercial product.

Applications follow NIH small-business parent-announcement cadence. NIH SEED states that standard application due dates are September 5, January 5, and April 5, with weekend or federal-holiday dates moved to the next business day. Applicants should confirm the exact receipt date in eRA Commons or Grants.gov for the cycle they use.

The practical risks are fit and mechanism choice. SBIR is for the small business applicant; teams that need a formal nonprofit research institution partner should use STTR, and companies with completed NIH Phase II work should look at Phase IIB or CRP instead.